Scotland's IbisVision wins £4.5 million in growth funding to launch US, EU business
Summary
The company is poised to ramp up sales in the US, where its estimated there are around 110 million eye tests annually, after receiving Food and Drug Administration (FDA) listing in March. IbisVision is already in discussions with a significant number of well-known eyecare brands to develop partnerships for its breakthrough platform.IbisVisions refractive technology means optometrists can run standard eye tests over the Internet and enable entire optical prescriptions to be conducted remotely. Our mission is simple to make eyecare readily available for anyone on the planet and that distance and time will never be an impediment to getting to an eye appointment.Adam Wolman commented: Not only are we delighted to build on our investment relationship with IbisVision, were also very excited about their plans to expand and set up base in our home market in the US. Providing multiple tests on a single cloud-based platform gives universal accessibility with a software as a service (SaaS) delivery model dramatically reducing capital expenditure. Its technology is used in healthcare kiosks across India, while the company has worked closely with the NHS to make eye appointments and aftercare more efficient and with the SBRI to help those whove suffered strokes.More information is available at